Research & Development



  可是呢,只要看到劉據,就等于看到了一個時時提醒他,證明他已經老了這一個現實。   金日見霍光準備了很多廢紙就打算離開書房,就好奇的道︰“你要這麼多廢紙做什麼?”深爱五月最新网站   雲音興奮地打開一個木盒,里面全是毛辣子的干品。尽情深爱网   這樣做是不對,你要有所選擇!”   “只不過燒了一片荒地而已,這也人還沒完沒了了。”97超碰av免费视频 第一二四章 明白人看劉據

Our discovery and development platforms for drug and cell-based therapies allow us to both create and retain significant value within our therapeutic franchise areas of cancer and inflammatory diseases. Scientists and physicians at Celgene are the driving force behind our success, enabling target-to-therapeutic platforms that integrate both small-molecule and cell-based therapies.

Connect? Registries

The Connect??Registries are observational, hematologic patient registry studies in Multiple Myeloma (Connect?MM), Chronic Lymphocytic Leukemia (Connect?CLL) and Myelodysplastic Syndromes/Acute Myeloid Leukemia (Connect?MDS/AML) and are sponsored by Celgene Corporation. These studies are designed to observe the routine care of patients through the course of their disease. Unlike clinical trials, registries do not require or provide any specific medications or healthcare services, but leave those decisions to the treating doctors and their patients.
Connect? Registries logo